Torax Medical Revenue and Competitors

Shoreview, MN USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Torax Medical's estimated annual revenue is currently $11M per year.(i)
  • Torax Medical's estimated revenue per employee is $251,000

Employee Data

  • Torax Medical has 44 Employees.(i)
  • Torax Medical grew their employee count by -14% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$30.6M1224%N/AN/A
#2
$18.6M7435%N/AN/A
#3
$75.6M30120%N/AN/A
#4
$12M484%N/AN/A
#5
$2.8M1110%N/AN/A
#6
$3M120%N/AN/A
#7
$24.6M985%N/AN/A
#8
$11.5M4621%N/AN/A
#9
$7.3M294%N/AN/A
#10
$13.8M55-10%N/AN/A
Add Company

What Is Torax Medical?

Torax® Medical, Inc. is a privately held medical device company headquartered in St. Paul, Minnesota, that develops and markets products designed to treat sphincter disorders utilizing its technology platform, Magnetic Sphincter Augmentation (MSA). Torax Medical markets both the LINX® Reflux Management System for the treatment of GERD and the FENIX® Continence Restoration System for the treatment of Fecal Incontinence (FI).

keywords:N/A

N/A

Total Funding

44

Number of Employees

$11M

Revenue (est)

-14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Torax Medical News

2022-04-20 - Gastroesophageal Reflux Disease (GERD) Devices Market is ...

... gastroesophageal reflux disease treatment devices, such as EndoGastric Solutions, Medigus Ltd., Torax Medical, Inc. and Mederi RF, Inc.

2022-04-19 - Gastroesophageal Reflux Disease (GERD) Devices Market ...

... gastroesophageal reflux disease treatment devices, such as EndoGastric Solutions, Medigus Ltd., Torax Medical, Inc. and Mederi RF, Inc.

2022-04-13 - Europe Gerd And Nerd Treatment Market Business ...

Torax Medical Valeant Pharmaceuticals Carbon Medical ... consumers of Gerd And Nerd Treatment industry are Pharmaceuticals and Healthcare,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.1M44N/AN/A
#2
$13.6M52-4%N/A
#3
$15.1M585%N/A
#4
$14.2M63-3%N/A
#5
$7.5M64-12%N/A